All About Bleeding: Information about rare bleeding disorders

GLOBAL

Phase I trial showed “promising" half-life extension results
Learn More

Entrepreneur with hemophilia B focuses on his goals. Read his story and others.

CSL Behring will donate FVIII concentrate to improve treatment in developing countries.

Choose and use a convenient Discussion Guide, to guide your conversation with doctors, teachers or employers.

Hear from thought leaders about making rare diseases a global priority.

Learn about the first and only factor XIII concentrate approved in U.S. to treat this extremely rare bleeding disorder.

Take a clear and simple look at the process of blood coagulation.